Alexis Irvin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexis Irvin has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Aria Eshraghi
Department of Infectious Diseases & Immunology, University of Florida, United States
2 shared publications - Nicole Adams
Department of Infectious Diseases & Immunology, College of Veterinary Medicine, University of Florida
2 shared publications - Anna M. Lundgren1 shared publication
- Ashley Clarke
Department of Infectious Diseases & Immunology, University of Florida , Gainesville, Florida, USA
1 shared publication - Danielle Hulvey
University of Florida
1 shared publication - Henry S. Heine
Institute for Therapeutic Innovation, University of Florida
1 shared publication
Latest Publications
- Open Access
- 1 November 2025
- Published by American Dairy Science Association in JDS Communications
- Vol. 6 (6) , 816-821
The microdrip method rapidly and efficiently enumerates bacterial colony-forming units in bovine milk
Summary: Investigating bacterially induced experimental mastitis requires reliable, precise, and reproducible enumeration of viable bacteria in milk. Standard microbiological methods to enumerate colony-forming units (cfu) are time consuming and expensive. In this work, we describe a microdrip method of cfu enumeration that not only reduces cost and time, but is also less variable, has increased reproducibility, and accommodates plating a greater number of technical replicates compared with standard bacterial enumeration methods. This suggests that the microdrip method is superior, considering statistical and practical considerations.
- 1 November 2025
- Published by American Dairy Science Association in JDS Communications
- Vol. 6 (6) , 816-821
Open AccessThe microdrip method rapidly and efficiently enumerates bacterial colony-forming units in bovine milk
Summary: Investigating bacterially induced experimental mastitis requires reliable, precise, and reproducible enumeration of viable bacteria in milk. Standard microbiological methods to enumerate colony-forming units (cfu) are time consuming and expensive. In this work, we describe a microdrip method of cfu enumeration that not only reduces cost and time, but is also less variable, has increased reproducibility, and accommodates plating a greater number of technical replicates compared with standard bacterial enumeration methods. This suggests that the microdrip method is superior, considering statistical and practical considerations.
- Open Access
- 12 December 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (6) , e0271323
Tolfenpyrad displays Francisella -targeted antibiotic activity that requires an oxidative stress response regulator for sensitivity
Francisella tularensis is a highly infectious Gram-negative bacterial pathogen capable of animal-to-human transmission. Due to its remarkable pathogenicity and potential for widespread public health impact, F. tularensis is classified as a high-priority pathogen by the Centers for Disease Control and Prevention. The historical development of Francisella as a bioweapon, coupled with the ease of engineering antibiotic-resistant strains, has spurred interest in the discovery of novel antibiotics. A library of drug-like compounds was screened for their ability to inhibit the growth of Francisella novicida , a biosafety level-2 surrogate for F. tularensis . Tolfenpyrad, a pesticide without previously identified antibacterial activity, was among the most potent inhibitors. Tolfenpyrad appears to uniquely target Francisella , as related species were sensitive, whereas bacteria in other genera were resistant. To identify Francisella pathways conferring sensitivity to tolfenpyrad, whole-genome sequencing of tolfenpyrad-resistant isolates was performed. Point mutations in two genes conferred resistance to osrR, a transcriptional regulator, and nuoM, a subunit of the electron transport chain. OsrR point mutants displayed attenuated growth in interferon gamma (IFN-γ)-stimulated macrophages but not in untreated macrophages, indicating that OsrR plays a role in resistance to IFN-γ-stimulated clearance of intracellular bacteria. OsrR point mutants are hypersensitive to reactive oxygen species, suggesting a mechanism by which they are rapidly cleared from IFN-γ-treated macrophages. This work identifies a novel Francisella -specific antibiotic activity and the metabolic pathways targeted. Moreover, we provide amino acid-level details of a Francisella protein that governs sensitivity to free radicals. IMPORTANCE: Francisella species are highly pathogenic bacteria that pose a threat to global health security. These bacteria can be made resistant to antibiotics through facile methods, and we lack a safe and protective vaccine. Given their history of development as bioweapons, new treatment options must be developed to bolster public health preparedness. Here, we report that tolfenpyrad, a pesticide that is currently in use worldwide, effectively inhibits the growth of Francisella . This drug has an extensive history of use and a plethora of safety and toxicity data, making it a good candidate for development as an antibiotic. We identified mutations in Francisella novicida that confer resistance to tolfenpyrad and characterized a transcriptional regulator that is required for sensitivity to both tolfenpyrad and reactive oxygen species.
- 12 December 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (6) , e0271323
Open AccessTolfenpyrad displays Francisella -targeted antibiotic activity that requires an oxidative stress response regulator for sensitivity
Francisella tularensis is a highly infectious Gram-negative bacterial pathogen capable of animal-to-human transmission. Due to its remarkable pathogenicity and potential for widespread public health impact, F. tularensis is classified as a high-priority pathogen by the Centers for Disease Control and Prevention. The historical development of Francisella as a bioweapon, coupled with the ease of engineering antibiotic-resistant strains, has spurred interest in the discovery of novel antibiotics. A library of drug-like compounds was screened for their ability to inhibit the growth of Francisella novicida , a biosafety level-2 surrogate for F. tularensis . Tolfenpyrad, a pesticide without previously identified antibacterial activity, was among the most potent inhibitors. Tolfenpyrad appears to uniquely target Francisella , as related species were sensitive, whereas bacteria in other genera were resistant. To identify Francisella pathways conferring sensitivity to tolfenpyrad, whole-genome sequencing of tolfenpyrad-resistant isolates was performed. Point mutations in two genes conferred resistance to osrR, a transcriptional regulator, and nuoM, a subunit of the electron transport chain. OsrR point mutants displayed attenuated growth in interferon gamma (IFN-γ)-stimulated macrophages but not in untreated macrophages, indicating that OsrR plays a role in resistance to IFN-γ-stimulated clearance of intracellular bacteria. OsrR point mutants are hypersensitive to reactive oxygen species, suggesting a mechanism by which they are rapidly cleared from IFN-γ-treated macrophages. This work identifies a novel Francisella -specific antibiotic activity and the metabolic pathways targeted. Moreover, we provide amino acid-level details of a Francisella protein that governs sensitivity to free radicals. IMPORTANCE: Francisella species are highly pathogenic bacteria that pose a threat to global health security. These bacteria can be made resistant to antibiotics through facile methods, and we lack a safe and protective vaccine. Given their history of development as bioweapons, new treatment options must be developed to bolster public health preparedness. Here, we report that tolfenpyrad, a pesticide that is currently in use worldwide, effectively inhibits the growth of Francisella . This drug has an extensive history of use and a plethora of safety and toxicity data, making it a good candidate for development as an antibiotic. We identified mutations in Francisella novicida that confer resistance to tolfenpyrad and characterized a transcriptional regulator that is required for sensitivity to both tolfenpyrad and reactive oxygen species.